ASX:IVX

Invion (IVX) Stock Price, News & Analysis

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
471,000 shs
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
IVX stock logo

About Invion Stock (ASX:IVX)

Invion Limited, a clinical-stage life-sciences company, researches and develops Photosoft technology for the treatment of various cancers, atherosclerosis, and infectious diseases in Australia. The company is developing IVX-PDT, a photosensitizer agent to treat skin cancers, as well as solid cancers, including lung, prostrate, ovarian, anogenital, and mesothelioma cancers. It has a research and development agreement with Hudson Institute of Medical Research to develop a novel photosensitiser for the treatment of a range of cancers; and research agreement with Peter MacCallum Cancer Centre to undertake pre-clinical and in-vitro studies on Invion's IVX-PDT Photodynamic therapy for ano-genital cancers, including penile and anal cancer. Invion Limited was incorporated in 2000 and is headquartered in Melbourne, Australia.

IVX Stock News Headlines

InVision Software AG IVX
Move Your Money Before May 22
The SIX WORDS That Could Destroy America... And The Value of Your Savings. He predicted the dangerous rise of inflation... the death of the 60/40 portfolio... and now, this 40-year market veteran and retirement expert is stepping forward with a new must-see warning for every American. It involves the world's most powerful investors, central bankers, and America's most bitter geopolitical rivals.
Stocks in August are DROPPING – Here’s Why
Gas Prices About to Skyrocket, Gas Economics 101
Move Your Money Before May 22
The SIX WORDS That Could Destroy America... And The Value of Your Savings. He predicted the dangerous rise of inflation... the death of the 60/40 portfolio... and now, this 40-year market veteran and retirement expert is stepping forward with a new must-see warning for every American. It involves the world's most powerful investors, central bankers, and America's most bitter geopolitical rivals.
Doctor Who 1960s movies get price cut
Meta Sparks a Sharp Sell-off in Tech Stocks
Markets Today: Global Stocks Slide as Bond Yields Climb
Man charged in Indiana County home invasion
See More Headlines
Receive IVX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Invion and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Sector
Medical
Industry
Drug Manufacturers - Specialty & Generic
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Net Income
$-1,500,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$4.39 million

Miscellaneous

Outstanding Shares
6,420,000,000
Free Float
N/A
Optionable
Not Optionable
Beta
1.20
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Key Executives

  • Mr. Thian Chew
    Executive Chairman & CEO
  • Ms. Melanie Jaye Leydin B.Bus (Age 51)
    C.A., Chief Financial Officer
  • Dr. Dean Naylor
    Head of Intellectual Property Development
  • Ms. Claire Newstead-Sinclair C.A.
    Company Secretary

IVX Stock Analysis - Frequently Asked Questions

What other stocks do shareholders of Invion own?
This page (ASX:IVX) was last updated on 4/26/2024 by MarketBeat.com Staff

From Our Partners